The panel details the clinical and economic burden when patients switch between agents in plaque psoriasis.
Bhavesh Shah, PharmD
Advertisement
Articles by Bhavesh Shah, PharmD
Bhavesh Shah, PharmD, and Robert Groves, MD, discuss the priorities payers should be taking into account when managing psoriasis treatment.
Advertisement
Latest Updated Articles
Impact of Switching Agents in Plaque PsoriasisPublished: December 1st 2021 | Updated:
Utilization Management in PsoriasisPublished: December 1st 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine
2
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
3
3 New Study Findings to Look Out for at Menopause Society 2025
4
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
5
